جست‌وجوی استاد و پژوهشگر

Virend Somersمشاهده پروفایل

استاد

• Cardiovascular Medicine
• Sleep Apnea
• Neurocirculatory Control
• +۹ مورد دیگر

Virend Somers, M.D., Ph.D. , is a Professor of Medicine at Mayo Clinic in Rochester, Minnesota, with primary appointments in the Department of Cardiovascular Medicine, and joint appointments in Physiology & Biomedical Engineering and Nephrology & Hypertension. He directs the Cardiovascular and Sleep Facilities within Mayo Clinic's Center for Clinical and Translational Science. Education: MB ChB, University of Natal D.Phil., University of Oxford Resident, Internal Medicine, University of Iowa Fellow, Cardiovascular Diseases, University of Iowa Hospitals and Clinics Research Interests: Dr. Somers' research centers on neural and vascular mechanisms in circulatory control, particularly in sleep disorders such as obstructive and central sleep apnea, hypertension, obesity, and heart failure. His team investigates autonomic nervous system regulation, chemoreflex responses, and vascular biology in humans. His work bridges basic physiology with clinical applications to improve cardiovascular outcomes. Publication Trends: His recent publications (2021–2025) show a strong emphasis on sleep-cardiovascular interactions, including blood pressure regulation during sleep, cardiovascular mortality in the context of comorbidities like obesity and COVID-19, and neurocardiological mechanisms in arrhythmias and syncope. His work frequently appears in high-impact journals such as Sleep , Journal of the American Heart Association , and Journal of Physiology . Scientific Awards: Alice Sheets Marriott Professor (2016) CTSA Mentor of the Year (2012) Distinguished Scientist in Cardiopulmonary Physiology, American College of Chest Physicians (2017) Stanford University World's Top 2% Scientists (2021) Lifetime Achievement Award, South African Society of Sleep Medicine (2012) Doctor Honoris Causa, Masaryk University (2007) Advising and Grants: Dr. Somers has mentored numerous trainees who have won national awards. His research is supported by four NIH R01 grants, a Dana Foundation grant, and a NATO grant. His leadership in collaborative research spans institutions in the U.S., Europe, and South Africa. Labs and Teams: He leads the Cardiovascular Facility and Sleep Facility at Mayo Clinic’s Center for Clinical and Translational Science, fostering interdisciplinary research on sleep and cardiovascular disease.

Thomas Hermannمشاهده پروفایل

پژوهشگر

• Auditory Data Science
• Interactive Sonification
• Smart Environments
• +۵ مورد دیگر

Dr. rer. nat. Thomas Hermann is a faculty member at Bielefeld University's Faculty of Engineering, leading the Ambient Intelligence Group and coordinating the Computer Science program. He specializes in sonification, auditory data science, and smart environments. Head of Ambient Intelligence Working Group Computer Science Program Coordinator Member of multiple academic advisory boards His research focuses on interactive sonification for biomedical applications, quantum systems, and smart environments. Key projects include ECG sonification for cardiac diagnosis, real-time auditory feedback in swimming, and sonic interfaces for AR cooperation. Recent publications span 2025 with Python-based sonification tools ( pya AGen ), quantum system sonification, and ST-elevation myocardial infarction monitoring. He contributes to open-access supplementary materials and interdisciplinary workshops. As a researcher , Hermann develops practical sonification frameworks like Panson for facial behavior analysis, CardioScope for portable ECG monitoring, and Base Cube One for smart environments. His work bridges academic research with industry applications.

• Cardiac Surgery
• Heart Valve Disease
• Transcatheter Valve Interventions
• +۷ مورد دیگر

Francesco Maisano, MD , is Full Professor of Cardiac Surgery at Vita-Salute San Raffaele University (Milan) since 2021, where he also serves as Director of the Cardiac Surgery Clinic and of the Valve Center at IRCCS San Raffaele Hospital. From 2014 to 2020 he held the Chair of Cardiac Surgery and directed the Department at University Hospital Zurich. Education & Training 1990 – MD, Catholic University of Rome 1994 – Clinical Fellowship, University of Alabama at Birmingham 1995 – Specialization in Cardiac Surgery, La Sapienza University of Rome Research Interests Professor Maisano’s work centres on innovative therapies for heart-valve disease, spanning surgical reconstruction, catheter-based interventions (TAVI, MitraClip, transcatheter tricuspid devices), and hybrid approaches. He leads translational programmes in biomedical engineering, multimodality cardiac imaging, and artificial-intelligence-guided interventions, with emphasis on the multidisciplinary “Heart Team” model for complex cardiovascular disease. His recent publications (2024-2025) demonstrate intense activity in transcatheter mitral and tricuspid repair, long-term durability of surgical mitral repair, AI-driven procedural guidance, and renal protection strategies during mechanical circulatory support. A dominant theme is translating imaging innovations and device concepts into first-in-human studies and large-scale registries. Scientific Awards & Recognitions European Society of Cardiology Silver Medal (2018) ICI Lifetime Achievement in Research & Teaching (2018) ICI Best Technology Parade Presentation (2010) C. Walton Lillehei Young Investigator Award (1999) Leadership & Grants He directs multiple postgraduate programmes, including Certificate of Advanced Studies (CAS) tracks at the University of Zurich in multimodality imaging, aortic valve, and mitral–tricuspid interventions. He is principal investigator on investigator-initiated grants, coordinates industry-partnered device trials, and mentors numerous doctoral and post-doctoral researchers. His team has filed >24 patents and spun off several cardiovascular start-ups. Labs & Teams At IRCCS San Raffaele he leads the Valve Science Center , a multidisciplinary hub integrating cardiac surgeons, interventional cardiologists, imaging specialists, biomedical engineers, and data scientists focused on next-generation valve repair/replacement technologies and personalised cardiovascular medicine.

• Computational Biology
• Health Informatics
• Machine Learning
• +۳ مورد دیگر

Julia Camps is a postdoctoral research associate at the University of Oxford, Department of Computer Science. Her work bridges Computational Biology and Health Informatics, focusing on cardiac digital twin development for precision medicine applications. She specializes in combining data-driven and mechanistic approaches for in silico clinical trials, particularly through Purkinje network modeling and ECG-based calibration. Education: Informatics Engineer (2014) and Master's in Artificial Intelligence (2015-2017) from Universitat Politècnica de Catalunya PhD in Computer Science (2017-2021) at Oxford, completed within the Computational Cardiovascular Science research group under Prof Blanca Rodriguez Current role: postdoc in Prof Rodriguez's group since 2021, focusing on post-myocardial infarction disease progression Software development: open-source cardiac digital twin tools available on GitHub Her research interests center on creating patient-specific cardiac digital twins using multimodal clinical data. This work enables virtual therapy evaluation and in silico clinical trials through: Integration of statistical inference and machine learning techniques Development of Purkinje network models from clinical ECG data Electrophysiological and repolarization sequence modeling Gait detection algorithms for Parkinson's disease applications Recent publications (2024-2025) demonstrate trends in: GPU-accelerated cardiac electrophysiology simulations (MonoAlg3D) Topology-informed ECG electrode localization Sex-specific electromechanical cardiac modeling Multi-modal characterisation of diabetic cardiac deterioration Pro-arrhythmic risk assessment for stem cell therapies

• Exercise Physiology
• Cardiovascular Health
• Exercise as Medicine
• +۳ مورد دیگر

Ulrik Wisløff is a Professor and Head of the Cardiac Exercise Research Group (CERG) at the Norwegian University of Science and Technology (NTNU), Department of Circulation and Medical Imaging. He also holds an Honorary Professorship at the University of Queensland, Australia, and serves as Head of Physical Performance at Rosenborg FC. His research focuses on exercise physiology, translating experimental findings into clinical applications, and developing health technologies like the PAI (Personal Activity Intelligence) metric. Wisløff leads CERG, a 55-member group renowned for groundbreaking studies on exercise in cardiovascular health, aging, and disease prevention. He has authored over 340 peer-reviewed papers, with 127,000+ citations, and been recognized as one of the world's top-cited exercise scientists. Key achievements include the Fitness Calculator (used by 80.5 million people) and PAI, a free app with 70 million users worldwide. Current projects include NorEx (9,700 patients with myocardial infarction) and ExPlas (Alzheimer’s cognitive function trials). Wisløff has mentored 22 postdocs and 38 PhD students, advancing the next generation of researchers. His leadership extends to innovative ventures like the 'My Medical Digital Twin' project, spun into Mia Health Ltd. Scientific contributions span exercise physiology, cardiovascular risk prediction, and high-intensity training efficacy. Awards include Norway’s highest honor in heart research (2020). Research spans molecules-to-society translational medicine, emphasizing global health impact through physical activity advocacy.

Xuan Liمشاهده پروفایل

پژوهشگر ارشد

• Cardiovascular Medicine
• Microtubule Cell Biology
• Inflammatory Diseases
• +۳ مورد دیگر

Dr. Xuan Li is a British Heart Foundation (BHF) Senior Basic Science Research Fellow and Principal Investigator in Cardiovascular Health at the Victor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge. Her research focuses on microtubule dysfunction in inflammatory cardiovascular diseases, particularly investigating how microtubule regulation impacts inflammasome activation and cardiomyocyte contractility in heart failure and atherosclerosis. Her academic journey includes medical training in China, a CRUK-funded PhD in biochemistry at the University of Birmingham, postdoctoral research in microtubule cell biology as an MRC Career Development Fellow at the MRC-LMB Cambridge, and specialized cardiovascular medicine training at the University of Cambridge. She established her independent research group at Cambridge, pioneering multidisciplinary approaches to study microtubule function in cardiovascular cells. Dr. Li's research program centers on the role of microtubule-regulating kinases (particularly MARK4) in cardiovascular pathologies. Her group employs advanced methodologies including cardiovascular disease models (atherosclerosis, myocardial infarction, cardiomyopathy), primary cell culture of cardiomyocytes and immune cells, single-cell physiology using IonOptix systems, and cutting-edge microscopy techniques. Key discoveries include the identification of MARK4 as a critical regulator of inflammasome activation in atherosclerosis and microtubule detyrosination in ischemic heart failure. Her publication record demonstrates consistent focus on microtubule-cytoskeleton interactions in cardiovascular inflammation, with recent high-impact papers in Nature, Nature Communications, and Circulation Research revealing novel therapeutic targets for heart disease treatment through microtubule modulation. Scientific recognition includes: British Heart Foundation Senior Basic Science Research Fellowship MRC Career Development Fellowship Cancer Research UK PhD Studentship Dr. Li's group currently pursues four major research thrusts: elucidating microtubule dysfunction mechanisms in cardiovascular disease development, dissecting inflammation-microtubule interplay in pathogenesis, establishing human cardiomyocyte culture systems for microtubule studies, and translating basic findings into diagnostic and therapeutic applications for cardiovascular diseases. Her work bridges fundamental cell biology with clinical cardiology to develop innovative treatments targeting the microtubule cytoskeleton.

• Pharmaceutical Technology
• Drug Delivery
• Nanoparticles
• +۴ مورد دیگر

Jouni Hirvonen is a Professor in the Division of Pharmaceutical Chemistry and Technology at the University of Helsinki's Faculty of Pharmacy. He serves as Supervisor for doctoral programmes in both the Doctoral Programme in Drug Research and the Doctoral Programme in Materials Research and Nanosciences. With an extensive publication record spanning over three decades, Hirvonen has contributed 384 research outputs and participated in 3 major research projects. His research interests focus on pharmaceutical technology, particularly in drug delivery systems, nanoparticles, and drug dissolution and absorption. His work bridges pharmaceutical chemistry with cutting-edge nanotechnology applications, developing innovative delivery systems for therapeutic agents. His research spans from fundamental pharmaceutical sciences to translational applications in regenerative medicine, immunotherapy, and cardiovascular pharmacology. The analysis of his recent publications reveals a strong focus on advanced drug delivery platforms, particularly utilizing nanoparticles, lipid-based systems, and biomaterials for targeted delivery. His work increasingly integrates microfluidic technology for precise nanoparticle preparation, with applications spanning cancer immunotherapy, cardiovascular repair, tendon regeneration, and inflammatory disease treatment. The trend shows a growing emphasis on combination therapies, RNA delivery, and cell-mediated drug delivery approaches. Hirvonen has received several prestigious awards throughout his career: CRS/Eurand Grand Prize Award on Innovations in Oral Drug Delivery Technologies (2007) Suomen Valkoisen Ruusun Ritarikunnan I luokan ritarimerkki (2013) The Young Scientist in the University of Kuopio (1993) University of Helsinki Quality Teaching Unit, Faculty of Pharmacy (2005) Visiting Professor award (2015) With 25 instances of supervising doctoral theses and numerous academic activities including conference organization, committee memberships, and editorial work, Hirvonen has made significant contributions to academic mentorship and institutional development. His research has been supported by projects including Generation Green, 3i REGENERATION, and IVIVRe. His work appears to involve collaboration with multiple research teams focusing on drug delivery applications across various therapeutic areas.

Anne-Mette Hvasمشاهده پروفایل

استاد

• Hematology
• Thrombosis and Hemostasis
• Platelet Function
• +۷ مورد دیگر

Anne-Mette Hvas is Professor and Dean at the Faculty of Health, Aarhus University, Denmark, where she leads academic and administrative initiatives in health sciences. Her role places her at the forefront of institutional strategy, research development, and interdisciplinary collaboration within clinical and translational medicine. Research Interests: Her work spans hematology, coagulation, platelet biology, neonatal hemostasis, and endocrinology. She investigates thrombotic and bleeding disorders in clinical contexts such as nephrotic syndrome, pregnancy, cancer surgery, and stroke. Her research integrates physiological, pharmacological, and clinical perspectives to improve patient outcomes. The recent publications reflect a strong focus on thrombin generation, platelet reactivity, endothelial dysfunction, and red blood cell behavior in acute and chronic conditions. These studies often involve multicenter collaborations and contribute to evidence-based practices in thromboprophylaxis, surgical safety, and stroke management. Scientific Contributions: Active research in hemostasis and thrombosis across diverse patient populations Leadership in clinical studies on anticoagulation, HIPEC, and neonatal platelet function Investigations into hormonal and cardiovascular aspects of Turner syndrome Advising and Grants: While specific advisees are not listed, her leadership in multiple funded research projects suggests mentorship of junior researchers and clinicians. She has led projects on platelet function in preterm neonates and coagulation in surgical oncology, indicating grant acquisition and team coordination capabilities. Labs and Teams: Though specific lab names are not mentioned, her work implies collaboration with clinical research teams in hematology, neonatology, oncology, and obstetrics at Aarhus University Hospital and affiliated centers.

Eldrin F. Lewisمشاهده پروفایل

استاد

• Heart Failure
• Cardiovascular Medicine
• Quality of Life Assessment
• +۴ مورد دیگر

Eldrin F. Lewis, MD, MPH is the Simon H. Stertzer, MD, Professor of Medicine and Chief of the Division of Cardiovascular Medicine at Stanford University School of Medicine. He holds a University Medical Line Professorship within the Department of Medicine - Cardiovascular Medicine and is a member of the Cardiovascular Institute. Dr. Lewis earned his medical degree from the Perelman School of Medicine at the University of Pennsylvania (1995), completed his Internal Medicine Residency (1998), Cardiovascular Disease Fellowship (2001), and Heart Transplant Fellowship (2002), all at Brigham and Women's Hospital in Massachusetts. He maintains board certification in Cardiovascular Disease (2024) and Advanced Heart Failure and Transplant Cardiology (2025) through the American Board of Internal Medicine. As an internationally recognized expert in heart failure, heart transplant, and quality of life for heart failure patients, Dr. Lewis' research focuses on patient-reported outcomes, quality of life assessment, and the integration of digital health technologies into cardiovascular care. His fundamental principle is that "there is more to life than death," emphasizing that cardiovascular care should help patients not only survive but also enjoy the best possible quality of life. His extensive publication record includes nearly 200 peer-reviewed articles in top journals including the New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, JAMA Cardiology, and JAMA Internal Medicine. His recent work (2024-2025) demonstrates strong focus on heart failure treatment optimization, diversity in clinical trials, pulmonary congestion assessment, and the implementation of quadruple medical therapy for heart failure patients. Joel Gordon Miller Award for community service and leadership from the University of Pennsylvania School of Medicine Minority Faculty Development Award recognizing research potential of young physicians Robert Wood Johnson Foundation grant for quality of life assessment research Fellow of the American College of Cardiology Member of the American Heart Association Research Committee Dr. Lewis serves as a Postdoctoral Faculty Sponsor for Phenesse Dunlap and has received significant research support from the National Heart, Lung and Blood Institute, National Institutes of Health, and the Robert Wood Johnson Foundation. He is deeply committed to expanding clinical research initiatives at Stanford, forming partnerships with community cardiologists, and leveraging Silicon Valley's digital technology expertise for patient monitoring and treatment optimization. His leadership includes serving on the AHA Founders Affiliate Board of Directors, chairing the Council on Clinical Cardiology, and participating in the FDA Task Force for Standardization of Definitions for Endpoint Events in Cardiovascular Trials.

• Biomaterials
• Regenerative Medicine
• Tissue Engineering
• +۴ مورد دیگر

Prof. Elisabeth Engel López leads the Biomaterials for Regenerative Therapies group at the Institute for Bioengineering of Catalonia (IBEC) and serves as a Professor at the Technical University of Catalonia. With over 80 publications in JCR journals, her work focuses on designing biomaterials and scaffolds for in vitro/in vivo regenerative medicine, emphasizing cellular response mechanisms and translational applications. Developing lactate-releasing systems for metabolic modulation Advancing 3D bioprinting for tissue-specific models Engineering angiogenic and osteogenic biomaterials Her research bridges fundamental studies with industrial partnerships, including pharmaceutical and biomedical device companies, and contributes to European collaborative projects. She received the Barcelona City Award for technological research and has delivered numerous invited lectures. Her group explores substrate stiffness, ion release, and microenvironmental cues to control cell behavior in cardiac, neural, and bone regeneration contexts.

Craig Morrellمشاهده پروفایل

استاد

• Platelet Biology
• Vascular Inflammation
• Thrombosis
• +۵ مورد دیگر

Craig Morrell is a Professor at the University of Rochester School of Medicine and Dentistry , with joint appointments in the Departments of Medicine , Microbiology and Immunology , and Pathology and Laboratory Medicine . He serves as Associate Director of the Aab Cardiovascular Research Institute . Education: Sc.B. in Biology, Brown University (1995) D.V.M. , Tufts University School of Veterinary Medicine (2000) Ph.D. in Pathobiology, Johns Hopkins University (2005) His research examines the interface between platelets, vascular biology, and immune cells , focusing on platelet roles in thrombosis, inflammation, and immune regulation. Using advanced mouse models , his lab investigates platelet-derived mediators like β2M and PF4 in diseases such as malaria, stroke, and myocardial infarction. Article trends highlight platelets' dual roles in thrombosis and immune modulation , with recurring themes in vascular inflammation , ERK5 signaling , and age-related immune dysfunction . Scientific Awards: Kenneth M. Brinkous Young Investigators Prize (2008) Deans Gift research award (2006) Multiple travel scholarships and fellowships (2003-2005) Pathology Award-Excellence in Pathology (2000) Mentoring and Teaching : He has mentored 8 doctoral students , 7 undergraduates , and 6 postdoctoral fellows , with a focus on diversity. He serves on thesis committees and the URMC MSTP (MD/PhD) admissions committee . Labs and Collaborations : Leads the Morrell Lab at the Aab Cardiovascular Research Institute, collaborating with institutions like Johns Hopkins and Medical College of Wisconsin.

Robert T. Tranquilloمشاهده پروفایل

استاد

• Tissue Engineering
• Cardiovascular Tissue Engineering
• Vascular Grafts
• +۷ مورد دیگر

Robert T. Tranquillo serves as a Distinguished McKnight University Professor in the Department of Biomedical Engineering at the University of Minnesota's College of Science and Engineering. His research focuses on developing biologically-engineered vascular grafts, heart valves, and vein valves using tissue engineering approaches. Notably, his lab has demonstrated that their engineered material, produced by skin cells (fibroblasts), has the capacity to grow, which may transform the treatment of pediatric congenital heart defects. Tranquillo's research interests center on cardiovascular tissue engineering, particularly the development of "off-the-shelf" vascular grafts and heart valves. His lab fabricates tissue-equivalents by entrapping fibroblasts in fibrin gel and constraining cell-mediated gel compaction to create aligned fibrin structures. Using bioreactors, they stimulate cells to replace aligned fibrin with collagenous matrix, creating tubes suitable for surgical implantation. Upon decellularization, these become non-immunogenic replacements that support host recellularization and growth. His current work focuses on transcatheter heart valves and vein valves, combining engineered matrix tubes with stent technology, and conferring hemocompatibility using stem cell and small molecule strategies. A key aspect of his research investigates contact guidance—the ability of cells to sense and align with fibers—which is crucial for creating tissues with prescribed alignment. His publication record shows consistent output in top journals including Nature Communications, Science Translational Medicine, and PNAS, with recent work focusing on contact guidance mechanisms, pediatric valve conduits, and transcatheter valve development. His research demonstrates a clear trajectory from fundamental biomechanics to translational applications in cardiovascular medicine. Distinguished McKnight University Professor (prestigious University of Minnesota honor) Tranquillo has mentored over 40 PhD students and postdocs who have gone on to prominent positions in academia (professors at UCLA, Rutgers, Penn State), industry (Medtronic, Abbott, Boston Scientific), and government (NSF, NRO). His lab has received substantial research funding supporting their work on tissue-engineered cardiovascular replacements. The Tranquillo Research Group maintains an active website detailing their current projects and methodologies. The Tranquillo Research Group operates within the Department of Biomedical Engineering at the University of Minnesota, with laboratory facilities focused on tissue engineering, biomechanics, and cardiovascular device development. Their work bridges fundamental cell-matrix interactions with translational applications for cardiovascular disease treatment.

Jenni Ilomakiمشاهده پروفایل

دانشیار

• Clinical Pharmacy
• Pharmacoepidemiology
• Public Health
• +۳ مورد دیگر

Associate Professor Jenni Ilomaki holds a position at Monash University's Centre for Medicine Use and Safety. With expertise in clinical pharmacy, epidemiology, and public health, she leads a research group analyzing administrative claims data. Her work spans collaborations with governmental and non-governmental organizations globally, yielding over 150 peer-reviewed publications and $4 million in grants. She previously served as Chair of ASCEPT's Pharmacoepidemiology Special Interest Group and currently serves as Science Lead for the Monash Addiction Research Centre and Executive Editor of the British Journal of Clinical Pharmacology. Education includes a Bachelor of Science (Pharmacy) from the University of Kuopio (1999) and Master of Science (Pharmacy) from the University of Kuopio (2004). She completed a PhD in alcohol epidemiology at the University of Eastern Finland (2011) and a postdoc at the University of South Australia (2011-2014). Notable recognitions include Young Epidemiologist of the Year (2011) and the Ronald D. Mann Best Paper Award (2021). Key research focuses on quality use of medicines, medicine safety, large population studies, and innovative epidemiological methods. Major projects include developing clinical decision support tools for cardiovascular prevention, analyzing preventable hospitalizations in aged care, and investigating psychotropic medication trends in youth. Her work contributes to UN Sustainable Development Goals related to health equity and non-communicable disease reduction. Recent publications emphasize drug repurposing (e.g., SGLT2 inhibitors), opioid prescribing patterns, hip fracture outcomes, and dementia detection algorithms. She chairs multinational studies on stroke and myocardial infarction cost burdens, demonstrating interdisciplinary impact across pharmacology, epidemiology, and health economics.

Kibret Mequanintمشاهده پروفایل

استاد

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۶ مورد دیگر

Dr. Kibret Mequanint is a full Professor at Western University's Department of Chemical and Biochemical Engineering, with cross-appointments in Biomedical Engineering. Holding a PhD from University of Stellenbosch and postdoctoral experience at Technical University of Darmstadt and McMaster University, his research bridges polymer science, materials engineering, and life sciences with applications in Biomaterials , Tissue Engineering , and Regenerative Medicine . His work spans both fundamental and translational research in cell-material interactions , polymer biomaterial design , and therapeutic radiation dosimeters , with technologies transferred to commercial applications. Leading scholar and educator with awards from NSERC, CIHR, and Western University Fellow of: American Institute for Medical and Biological Engineering (AIMBE), Ethiopian Academy of Sciences, International Union of Societies for Biomaterials Science and Engineering, Canadian Academy of Engineering Extensive editorial and panel service for NSERC, CIHR, and international journals His research program has produced over 170 refereed publications, focusing on conductive hydrogels , bioadhesives , and vascular tissue engineering . Recent work on endoscopy-deliverable bioadhesives and snake venom-derived hemostatic gels has attracted global media attention. He has served in leadership roles at the Canadian Biomaterials Society and university governance bodies including Senate and Board of Governors.

• Epidemiology
• Spatial Epidemiology
• Register-based Epidemiology
• +۴ مورد دیگر

Kristine Bihrmann serves as a Senior Researcher at the National Institute of Public Health, University of Southern Denmark. Her primary research area is geographical and register-based epidemiology, utilizing Denmark's extensive national health registries to investigate spatial patterns of disease occurrence and healthcare utilization. She has co-authored numerous studies on topics including cervical cancer screening, acute myocardial infarction, and social inequities in chiropractic care. Bihrmann's research interests center on epidemiology with a strong emphasis on spatial analysis and register-based methods. Key areas include chronic disease epidemiology (particularly cardiovascular diseases and cancer), social epidemiology examining socioeconomic disparities, and public health interventions. Her work often explores the interplay between geography, healthcare access, and health outcomes in the Danish population. Her recent publications demonstrate a consistent focus on spatial epidemiology and health services research. She frequently employs register-based cohort and cross-sectional designs to investigate how geographic factors influence healthcare utilization and disease outcomes. Notable themes include the impact of travel distance on preventive care and acute conditions, as well as social determinants of health across various medical conditions. No scientific awards were mentioned in the available information. Information regarding academic advising and research grants was not provided in the source material. Bihrmann conducts her research within the National Institute of Public Health, leveraging Denmark's unique health registries for population-based epidemiological studies. Her work contributes to understanding regional health disparities and informing public health policy in Denmark.